Surveillance for Distant Metastasis in Breast Cancer Patients Who Underwent Contemporary Management: A Report from the Korean Breast Cancer Society Survivor Research Group
View abstract on PubMed
Summary
This summary is machine-generated.Intensive imaging for breast cancer metastasis detection may lead to earlier diagnosis but does not improve breast cancer-specific survival (BCSS). Current treatments are not enhanced by frequent surveillance imaging in asymptomatic patients.
Area Of Science
- Oncology
- Radiology
- Clinical Medicine
Background
- Current guidelines advise against routine imaging for metastasis in asymptomatic breast cancer patients.
- Advancements in therapeutics and diagnostics necessitate re-evaluating intensive metastasis surveillance.
- This study investigates the clinical efficacy of intensive imaging in detecting distant metastasis.
Purpose Of The Study
- To investigate the association between intensive imaging studies and survival outcomes in breast cancer patients.
- To determine if increased surveillance impacts distant metastasis-free survival and breast cancer-specific survival (BCSS).
Main Methods
- Retrospective review of 4130 breast cancer patients from 11 Korean hospitals (2010-2011).
- Patients categorized into high-intensive and low-intensity imaging groups based on physician decisions during the disease-free period.
- Analysis included multivariable and propensity score matching.
Main Results
- High-intensive screening correlated with earlier detection of distant metastasis, particularly to bone and lung (p < 0.001).
- Poorer 5-year breast cancer-specific survival (BCSS) observed in the high-intensity group (p < 0.001).
- No significant association found between screening intensity and BCSS in multivariable or propensity score matching analyses.
Conclusions
- Intensive imaging facilitates earlier detection of distant metastasis, especially to bone and lung.
- Despite earlier detection, intensive surveillance did not demonstrate an association with improved BCSS with current treatments.
- Reassessment of current guidelines regarding intensive metastasis surveillance in asymptomatic breast cancer patients is warranted.

